Higher anti‐tumour efficacy of platinum(IV) complex LA‐12 is associated with its ability to bypass M‐phase entry block induced in oxaliplatin‐treated human colon cancer cells

OBJECTIVES: Therapeutic potential of conventionally used platinum‐based drugs in treatment of colorectal tumours has been limited due to high incidence of tumour resistance to them and to their severe side effects. This evokes a search for more suitable anti‐cancer drugs. We have compared ability of...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cell Prolif
Главные авторы: Vondálová Blanářová, O., Jelínková, I., Hyršlová Vaculová, A., Sova, P., Hofmanová, J., Kozubík, A.
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2013
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6496914/
https://ncbi.nlm.nih.gov/pubmed/24118195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12061
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы